Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity.
epithelioid
gene expression
immunogenicity
pleural mesothelioma
sarcomatoid
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Apr 2021
07 Apr 2021
Historique:
received:
24
02
2021
revised:
29
03
2021
accepted:
02
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Malignant pleural mesothelioma (MPM) is an aggressive malignancy associated with asbestos exposure. Median survival ranges from 14 to 20 months after initial diagnosis. As of November 2020, the FDA approved a combination of immune checkpoint inhibitors after promising intermediate results. Nonetheless, responses remain unsatisfying. Adequate patient stratification to improve response rates is still lacking. This retrospective study analyzed formalin fixed paraffin embedded specimens from a cohort of 22 MPM. Twelve of those samples showed sarcomatoid, ten epithelioid differentiation. Complete follow-up, including radiological assessment of response by modRECIST and time to death, was available with reported deaths of all patients. RNA of all samples was isolated and subjected to digital gene expression pattern analysis. Our study revealed a notable difference between epithelioid and sarcomatoid mesothelioma, showing differential gene expression for 304/698 expressed genes. Whereas antigen processing and presentation to resident cytotoxic T cells as well as phagocytosis is highly affected in sarcomatoid mesothelioma, cell-cell interaction via cytokines seems to be of greater importance in epithelioid cases. Our work reveals the specific role of the immune system within the different histologic subtypes of MPM, providing a more detailed background of their immunogenic potential. This is of great interest regarding therapeutic strategies including immunotherapy in mesothelioma.
Identifiants
pubmed: 33917061
pii: cancers13081761
doi: 10.3390/cancers13081761
pmc: PMC8067687
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Crit Rev Oncol Hematol. 2016 Jan;97:303-11
pubmed: 26467073
Transl Lung Cancer Res. 2015 Feb;4(1):55-66
pubmed: 25806346
Biol Chem. 2004 Nov;385(11):1017-27
pubmed: 15576321
Semin Cancer Biol. 2015 Dec;35:145-53
pubmed: 26297892
J Surg Res. 2015 Jun 1;196(1):23-32
pubmed: 25791825
Cancer Biol Ther. 2005 Mar;4(3):342-6
pubmed: 15846066
Clin Cancer Res. 2010 Dec 1;16(23):5805-13
pubmed: 20956618
J Biomed Biotechnol. 2011;2011:918471
pubmed: 22190859
Lancet. 2021 Jan 30;397(10272):375-386
pubmed: 33485464
J Thorac Oncol. 2016 Oct;11(10):1765-73
pubmed: 27418105
J Immunol. 1999 Oct 15;163(8):4224-31
pubmed: 10510359
J Cell Mol Med. 2021 Jan;25(2):639-651
pubmed: 33336901
Biochim Biophys Acta. 2004 Nov 29;1695(1-3):225-33
pubmed: 15571818
PLoS One. 2014 Sep 05;9(9):e106742
pubmed: 25192022
Virchows Arch. 2017 Apr;470(4):401-410
pubmed: 28191612
Am J Pathol. 2011 Mar;178(3):956-63
pubmed: 21356346
Clin Cancer Res. 2018 Jun 15;24(12):2859-2872
pubmed: 29602801
Br J Cancer. 2000 Aug;83(3):298-306
pubmed: 10917542
Expert Opin Ther Targets. 2010 Apr;14(4):435-42
pubmed: 20230195
Respiration. 2008;75(2):121-33
pubmed: 18332619
Front Oncol. 2020 Feb 21;10:187
pubmed: 32154179
Nat Med. 2007 Jul;13(7):828-35
pubmed: 17603493
Transl Lung Cancer Res. 2020 Feb;9(Suppl 1):S28-S38
pubmed: 32206568
Am J Surg Pathol. 1982 Apr;6(3):215-22
pubmed: 7102900
Oral Oncol. 2004 Mar;40(3):257-63
pubmed: 14747056
Ann Oncol. 2020 Dec;31(12):1734-1745
pubmed: 32976938
Br J Cancer. 2017 Oct 24;117(9):1341-1348
pubmed: 28817839
Cancer Immunol Res. 2016 Dec;4(12):1038-1048
pubmed: 27856426
Theranostics. 2017 Apr 7;7(6):1543-1588
pubmed: 28529637
Oncoimmunology. 2016 Nov 28;6(1):e1261241
pubmed: 28197385
Semin Oncol. 2017 Aug;44(4):239-253
pubmed: 29526252
Semin Cancer Biol. 2008 Aug;18(4):288-95
pubmed: 18468453
J Thorac Oncol. 2018 Nov;13(11):1638-1654
pubmed: 30121394
Int J Mol Sci. 2018 Mar 30;19(4):
pubmed: 29601534
Lancet Respir Med. 2019 Jul;7(7):569-580
pubmed: 31103412
J Thorac Cardiovasc Surg. 2008 Apr;135(4):823-9
pubmed: 18374762
Ann Thorac Surg. 2017 Mar;103(3):962-966
pubmed: 27765170
J Thorac Oncol. 2011 May;6(5):896-904
pubmed: 21358344
Clin Cancer Res. 2012 Feb 1;18(3):598-604
pubmed: 22065079
Cancer Res. 2001 Jun 15;61(12):4756-60
pubmed: 11406548
Int J Oncol. 2007 Nov;31(5):1127-32
pubmed: 17912439
Yonsei Med J. 2007 Feb 28;48(1):11-23
pubmed: 17326240
J Exp Med. 2012 Mar 12;209(3):479-94
pubmed: 22329991
Int J Cancer. 2006 Sep 15;119(6):1303-11
pubmed: 16642474
J Thorac Oncol. 2016 Feb;11(2):142-54
pubmed: 26811225
J Clin Oncol. 2003 Jul 15;21(14):2636-44
pubmed: 12860938
J Cancer. 2019 Jun 2;10(13):2969-2981
pubmed: 31281474
Cancer. 2011 Nov 15;117(22):5234-44
pubmed: 21523763
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Bioinformatics. 2012 Jun 1;28(11):1546-8
pubmed: 22513995
Invest Ophthalmol Vis Sci. 2005 Jan;46(1):88-95
pubmed: 15623759
Front Oncol. 2019 Dec 06;9:1366
pubmed: 31867277
J Thorac Oncol. 2018 Aug;13(8):1189-1203
pubmed: 29723687
Science. 1987 Jun 19;236(4808):1570-3
pubmed: 2438772
Int J Mol Sci. 2019 Jan 03;20(1):
pubmed: 30609805
Nat Genet. 2016 Apr;48(4):407-16
pubmed: 26928227
Nat Rev Cancer. 2015 Dec;15(12):712-29
pubmed: 26597527
Cancer Manag Res. 2019 Sep 24;11:8711-8720
pubmed: 31576173
FEBS J. 2008 Jan;275(2):350-61
pubmed: 18093185
Cancer Immunol Res. 2013 Aug;1(2):85-91
pubmed: 24777499
J Thorac Oncol. 2019 Feb;14(2):276-287
pubmed: 30316012
Exp Eye Res. 2004 May;78(5):957-71
pubmed: 15051477
Cancer Sci. 2020 Aug;111(8):2895-2906
pubmed: 32530527
Cancer Metastasis Rev. 1988 Apr;7(1):39-50
pubmed: 3293831
Virchows Arch. 2014 Dec;465(6):679-85
pubmed: 25300229
Nature. 1988 Nov 17;336(6196):244-6
pubmed: 3194009
Front Immunol. 2019 Feb 27;10:333
pubmed: 30873179
J Biol Chem. 2010 Jul 23;285(30):23276-84
pubmed: 20463012
Cancer. 2001 Sep 1;92(5):1224-30
pubmed: 11571736
Transl Lung Cancer Res. 2020 Jun;9(3):924-933
pubmed: 32676358
Immunogenetics. 2004 Jul;56(4):244-53
pubmed: 15258706
Turk J Gastroenterol. 2019 Jan;30(1):15-20
pubmed: 30301709
Immunogenetics. 2006 Jul;58(7):503-10
pubmed: 16705407
Cytokine Growth Factor Rev. 2016 Oct;31:61-71
pubmed: 27578214
Int J Biochem Cell Biol. 2004 Jan;36(1):9-16
pubmed: 14592528
Clin Exp Dermatol. 2007 Jul;32(4):405-16
pubmed: 17490399
Curr Mol Med. 2017;17(6):436-449
pubmed: 29256349
Urol Int. 2002;69(4):266-72
pubmed: 12444281
Cancer Manag Res. 2020 Aug 26;12:7881-7890
pubmed: 32922086
Transl Lung Cancer Res. 2017 Jun;6(3):259-269
pubmed: 28713671
Oncotarget. 2017 Sep 21;8(52):89722-89735
pubmed: 29163783
Dtsch Arztebl Int. 2013 May;110(18):319-26
pubmed: 23720698
Transl Lung Cancer Res. 2020 Jun;9(3):639-645
pubmed: 32676326
Essays Biochem. 2011 Sep 7;50(1):249-64
pubmed: 21967061
Front Oncol. 2020 Apr 30;10:641
pubmed: 32426283
Cancer Metastasis Rev. 2006 Sep;25(3):409-16
pubmed: 16951987
Oncoimmunology. 2017 Jan 6;6(2):e1278330
pubmed: 28344893
Nature. 1990 Jul 19;346(6281):281-4
pubmed: 2374594
Tumour Biol. 2012 Dec;33(6):2135-41
pubmed: 22886525
Annu Rev Cell Dev Biol. 2011;27:291-320
pubmed: 21663443
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
J Immunother Cancer. 2020 Mar;8(1):
pubmed: 32188703
Cancers (Basel). 2011 Mar 29;3(2):1672-90
pubmed: 24212778
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Cancer Prev Res (Phila). 2016 May;9(5):406-414
pubmed: 26935421
J Biol Chem. 2006 Sep 8;281(36):26408-18
pubmed: 16835231
Int J Cancer. 2001 Jan 20;95(1):12-7
pubmed: 11241304
J Exp Med. 1993 Feb 1;177(2):265-72
pubmed: 8426105
J Biol Chem. 2012 Oct 5;287(41):33926-33
pubmed: 22879588
J Thorac Oncol. 2016 Oct;11(10):1755-64
pubmed: 27418106
Cell Death Dis. 2014 Apr 10;5:e1167
pubmed: 24722292
J Thorac Oncol. 2015 Sep;10(9):1240-1242
pubmed: 26291007
Cell Immunol. 2006 Mar;240(1):1-4
pubmed: 16876776
J Immunother Cancer. 2020 Jun;8(1):
pubmed: 32581053
J Oral Pathol Med. 2015 Sep;44(8):571-7
pubmed: 25338738
Int J Oncol. 2000 Jul;17(1):5-12
pubmed: 10853011
Ann Oncol. 2004 Feb;15(2):257-60
pubmed: 14760119
Transl Lung Cancer Res. 2020 Feb;9(Suppl 1):S39-S46
pubmed: 32206569
Mod Pathol. 2012 Jul;25(7):1011-22
pubmed: 22388762
Sci Signal. 2011 Nov 15;4(199):ra75
pubmed: 22087031
Int J Oncol. 2008 Dec;33(6):1177-85
pubmed: 19020750